Steven J. TRZASKA, Appellant v. L‘OREAL USA, INC.; L‘Oreal, S.A.
No. 15-3810
United States Court of Appeals, Third Circuit
Argued November 16, 2016 (Opinion filed: July 25, 2017) Amended August 22, 2017
865 F.3d 155
(Argued) George P. Barbatsuly, Laura Scully, Christopher R. Carton, K&L Gates, One Newark Center, 10th Floor, Newark, NJ 07102
(Argued) Eric A. Savage, Littler Mendelson, 900 Third Avenue, 8th Floor, New York, NY 10022, Counsel for Appellees
Before: AMBRO, CHAGARES, and FUENTES, Circuit Judges
OPINION OF THE COURT
AMBRO, Circuit Judge
I. BACKGROUND
Beginning in 2004, Trzaska was employed as the head of L‘Oréal USA‘s regional patent team in Clark, New Jersey, overseeing the process by which the latter would patent the company‘s newly developed products and inventions. The process would begin when an inventor submitted to the patent team an “invention disclosure” for a new product describing its potentially patentable subject matter. A patent attorney on the team then vetted the invention disclosure to determine the product‘s patentability by interviewing the inventor and searching L‘Oréal USA‘s internal database to confirm that the subject matter of the product did not already exist. If the patent team determined that the product was patentable, an attorney prepared the necessary paperwork and submitted a patent application to the United States Patent and Trademark Office (“USPTO“).
As with any legal practitioner, the attorneys on L‘Oréal USA‘s patent team were required to follow various ethical standards known as Rules of Professional Conduct that guide and regulate the legal profession. Because he was admitted to practice law in Pennsylvania and before the USPTO, both the Rules of Professional conduct established by the Supreme Court of Pennsylvania and the professional rules promulgated by the USPTO (collectively, the “RPCs“) governed Trzaska‘s conduct. In relevant part, these RPCs barred attorneys from filing frivolous or bad-faith patent applications or from
L‘Oréal, S.A.—the French parent company of L‘Oréal USA (collectively, “L‘Oréal“)—established a global quota of patent applications that each regional office must file each year. In 2014, the annual quota for Trzaska‘s team was 40 patent applications. Management officials at L‘Oréal told Trzaska and his team members that, if they failed to meet that quota, “there would be consequences which would negatively impact their careers and/or continued employment.” J.A. at 32. At the same time, L‘Oréal adopted an initiative to improve the quality of patent applications it filed with the USPTO. Adopting this company policy resulted in fewer invention disclosures submitted to the patent team for vetting.
With two competing company policies in place—one that required the patent team to meet an annual minimum of patent applications and one that effectively reduced the amount of invention disclosures that could be evaluated—Trzaska‘s team found itself in a predicament. According to several members of the team, there were very few patentable products submitted to it for vetting while L‘Oréal continued to demand that the team meet the annual quota. Consequently, the patent team did not believe it was able to meet the mandatory quota for 2014 without filing patent applications for products that it did not in good faith believe were patentable. And, as L‘Oréal had threatened, if the team did not meet that quota, the patent attorneys’ job security would be in peril.
In the hope of resolving this professional Catch-22, Trzaska approached his superiors. He explained that neither he nor his team would be willing to file any patent applications for products that they in good faith believed were not patentable. He advised management that if any attorney on the patent team filed such a patent application, he or she would be in violation of the ethical standards—or RPCs—to which they were bound as licensed patent attorneys. Though Trzaska did not identify any offending patent application that he nonetheless was instructed to file, he informed his superiors that he would not do so should he come across one, even if that meant that the annual quota would not be met.
Apparently L‘Oréal did not receive well Trzaska‘s protest. In the weeks following Trzaska‘s meeting with management, L‘Oréal offered him two severance packages that he could accept so long as he left the company. If he chose not to leave, he was instructed to “go back to [his] office and get back to work.” J.A. at 34. After he rejected both severance packages offered, L‘Oréal fired Trzaska, stating that his position was no longer needed.
Trzaska brought suit in District Court against both L‘Oréal entities for wrongful
The District Court dismissed Trzaska‘s claims under
II. JURISDICTION AND STANDARD OF REVIEW
We have jurisdiction over final orders of the District Court per
III. ANALYSIS
A. RPCs and CEPA Violations
“CEPA ... protect[s] employees from retaliatory actions by employers....” Blackburn v. United Parcel Serv., Inc., 179 F.3d 81, 91 (3d Cir. 1999) (quotations omitted). To that end, courts construe it flexibly. Id. It provides in relevant part:
An employer shall not take any retaliatory action against an employee because the employee does any of the following:
...
(c) Objects to, or refuses to participate in any activity, policy or practice which the employee reasonably believes: (1) is in violation of a law, or a rule or regulation promulgated pursuant to law ...; (2) is fraudulent or criminal ...; or (3) is incompatible with a clear mandate of public policy concerning the public health, safety or welfare or protection of the environment.
Following these guidelines, an allegation that an employer instructed, coerced, or threatened its patent attorney employee to disregard the RPCs binding him violates a clear mandate of public policy within the meaning of CEPA. See
First, “[a] patent by its very nature is affected with a public interest.” Blonder-Tongue Labs., Inc. v. Univ. of Ill. Found., 402 U.S. 313, 343 (1971) (quotations omitted). It “favors the maintenance of a well-functioning patent system.” Medtronic, Inc. v. Mirowski Family Ventures, LLC, 571 U.S. 191, 134 S. Ct. 843, 851 (2014); see also King Drug Co. of Florence, Inc. v. Smithkline Beecham Corp., 791 F.3d 388, 394 (3d. Cir. 2015) (“A patent, consequently, is a special privilege designed to serve the public....“) (quotations omitted)). Accordingly, “the relationship of attorneys to the Patent Office requires the highest degree of candor and good faith,” Kingsland v. Dorsey, 338 U.S. 318, 319 (1949) (quotations omitted), which includes adherence to the USPTO‘s RPCs and regulations governing the submission of good-faith, non-frivolous patent applications. A well-functioning patent system cannot exist without it. An employer‘s directive to its employees to disregard these RPCs thus crosses a clear mandate of public policy. Moreover, while the USPTO‘s RPCs fall within CEPA‘s public policy provision,
Second, rules of professional conduct in general can underlay a CEPA violation. “In New Jersey, [the courts] are deeply committed to the principle that an employer‘s right to discharge an employee carries a correlative duty to protect his freedom to decline to perform an act that would constitute a violation of a clear mandate of public policy.” Abbamont v. Piscataway Twp. Bd. of Educ., 138 N.J. 405, 424, 650 A.2d 958, 971 (1994) (quotations omitted). To stymie that duty finds the employer afoul of CEPA. See Parker v. M&T Chemicals, Inc., 236 N.J. Super. 451, 460-61, 566 A.2d 215, 219-20 (N.J. Super. Ct. App. Div. 1989) (in-house patent counsel‘s adherence to a state Supreme Court‘s ethical Rules of
Given these two principles—that the abuse of the patent application system and the violation of Rules of Professional Conduct harm the public‘s interest—an employer‘s policy effecting the disregard of the RPCs contravenes clear mandates of public policy within the meaning of CEPA. Thus an allegation that an employer promulgates such a policy serves as an adequate basis to bring a CEPA claim. See Tartaglia v. UBS PaineWebber Inc., 197 N.J. 81, 112, 961 A.2d 1167, 1182-83 (2008) (CEPA requires “an expression by the employee of a disagreement with a corporate policy, directive, or decision based on a clear mandate of public policy,” and in those contexts the “termination [itself] violates a public policy mandate.“)
The District Court determined that the applicable RPCs could not serve as a basis for a CEPA violation because they do not regulate L‘Oréal‘s business practices. That conclusion may be correct, but the basis of the CEPA claim here is not L‘Oréal‘s violation of the RPCs; rather, it is the instruction to its employees that would result in the disregard of their RPC duties and hence violates a mandate of public policy. CEPA is clear: an employee cannot be terminated for refusing to participate in conduct that he reasonably believes violates public policy. This is especially so because we must construe the statute‘s protections liberally. See Blackburn, 179 F.3d at 90. Accordingly, the failure to follow instructions that effectively disregard RPCs forms a CEPA claim.
B. Trzaska‘s Allegations
The District Court determined that, regardless whether an employer‘s instruction to an employee that would result in the disregard of the employee‘s professional ethical standards can be the basis of a CEPA claim, Trzaska failed to plead adequately such a claim. It found that Trzaska did not allege that L‘Oréal had violated a law or public policy or that such a violation was imminent. His apparent failure to do so, the Court believed, was fatal to his CEPA claim. We disagree.
First, as stated above, professional ethical codes can serve as a basis to state a claim under CEPA when an employee is coerced to disregard them. In New Jersey
the sensible meaning of CEPA is that the objecting employee must have an objectively reasonable belief, at the time of objection or refusal to participate in the employer‘s offensive activity, that such activity is ... incompatible with a constitutional, statutory or regulatory provision, code of ethics, or other recognized source of public policy. Specific knowledge of the precise source of public policy is not required.
Mehlman v. Mobil Oil Corp., 153 N.J. 163, 193, 707 A.2d 1000, 1015 (1998). Trzaska‘s allegations thereby come within the scope of CEPA protection, especially in light of the
Second, we disagree with the District Court that Trzaska‘s CEPA claim should be brushed away because his “pleadings contain no evidence that [L‘Oréal] demanded or ordered that [he] or others relinquish their professional judgments or obligations.” Trzaska v. L‘Oréal USA, Inc. et al., Civil Action No. 2:15-cv-02713-SDW-SCM, 2015 WL 6687661, at *5 (D.N.J. Oct. 30, 2015). That statement misapplies the standard of review at the motion-to-dismiss stage. There a court must consider no more than whether the complaint establishes “enough facts to raise a reasonable expectation that discovery will reveal evidence of the necessary elements” of the cause of action. Connelly v. Lane Constr. Corp., 809 F.3d 780, 789 (3d Cir. 2016) (quoting Phillips v. Cty. of Allegheny, 515 F.3d 224, 234 (3d Cir. 2008) (quotation and alteration omitted)). A plaintiff‘s allegations must be accepted as true and construed in the light most favorable to him when determining if his complaint should be dismissed. Phillips, 515 F.3d at 231 (quotations omitted).
Trzaska‘s complaint has met this threshold. It alleges there was a company policy of meeting the patent application quota regardless whether the applications submitted were for products that he did not believe were patentable. He also claimed that he and other colleagues were implicitly instructed to disregard the RPCs in order to meet the quota and that his supervisors expressly rejected his concern about violating the RPCs. And, to close the circle, L‘Oréal threatened to terminate his employment if he did not meet the quota. J.A. at 32, 35-36. If these allegations are taken as true, which they must be for the purposes of deciding a motion to dismiss, Trzaska has alleged a colorable violation of CEPA. Whether he was in fact instructed to violate the RPCs is determined later in the litigation process.4
C. L‘Oréal, S.A.‘s Motion to Dismiss
L‘Oréal, S.A. filed a motion to dismiss Trzaska‘s appeal as to it because Trzaska did not initially file a notice of appeal as required by
A notice of appeal must specify the “judgment, order, or part thereof being appealed.”
The Polonski factors point to our jurisdiction. No doubt there is a connection between the specified and unspecified orders; they were issued the same day and relied exclusively on the same opinion. Given that Trzaska sought appellate review of that opinion, it is easy to infer his intention to appeal both orders that relied on it in dismissing his entire complaint against both defendants. Finally, L‘Oréal, S.A. has failed to demonstrate how it has been prejudiced and has not had a full opportunity to brief the issues. The Clerk of Court sent notice of the appeal to L‘Oréal, S.A.‘s counsel shortly after it was filed requesting that he enter his appearance. L‘Oréal, S.A. then waited five months to file its motion to dismiss the appeal. Most importantly, L‘Oréal, S.A. has had a full opportunity to brief the issues, which it has done. Therefore, because of the connection between the orders, Trzaska‘s inferred intent to appeal both of them, and the lack of prejudice to L‘Oréal, S.A., we deny L‘Oréal, S.A.‘s motion to dismiss the appeal.
IV. CONCLUSION
An instruction, coercion, or threat by an employer that would result in the disregard of obligatory ethical standards of one‘s profession violates a clear mandate of public policy within the meaning of CEPA. Under it, an employee cannot be terminated for refusing to engage in conduct in which he or she is prohibited from engaging. We therefore reverse the District Court‘s dismissal and remand the case for further proceedings without dismissing Trzaska‘s appeal as to L‘Oréal, S.A.
Steven J. TRZASKA, Appellant v. L‘OREAL USA, INC.; L‘Oreal, S.A.
No. 15-3810
United States Court of Appeals, Third Circuit
Argued November 16, 2016 (Opinion filed: July 25, 2017) Amended August 22, 2017
I agree with my learned colleagues that rules of professional conduct (“RPCs“) can serve as an adequate foundation for a claim under the New Jersey Conscientious Employee Protection Act (“CEPA“),
I.
The pertinent facts alleged in the amended complaint are as follows. Plaintiff Steven Trzaska was admitted to practice law in Pennsylvania in 1989 and admitted to practice before the United States Patent and Trademark Office in 1992. He began working for L‘Oréal, USA, Inc. (“L‘Oréal“) in 2004. Since at least the start of Trzaska‘s employment at L‘Oréal, L‘Oréal‘s parent company “set a predetermined numerical quota of how many patent applications it was to file globally on an annual basis.” Appendix (“App.“) 27. The reason for the quota, according to Trzaska, “[was] to maintain and bolster the reputation of [L‘Oréal] to financial analysts and shareholders following its stock, as innovative science-based players in the field of cosmetics.” App. 28. The global quota was unchanged from at least 2012.
Working within the contours of this quota became objectionable to Trzaska as of October 2014, and that month he complained about the quota to the Global CFO of the Research and Innovation Organization of the parent company. Specifically, Trzaska “advised that neither he nor the patent attorneys who reported to him were willing to file patent applications that the attorneys believed were not patentable....” App. 34. Thereafter, the head of Human Resources for Research in the United States offered Trzaska two options: a severance package if he would leave L‘Oréal‘s employment or that he could “go back to [his] office and get back to work.” App. 34. Trzaska received an offer for a more substantial severance package shortly thereafter but did not accept it. On December 8, 2014, L‘Oréal terminated Trzaska.
Notwithstanding Trzaska‘s issues with the quota—which was the same as previous years—the amended complaint reveals that Trzaska‘s team had 87.5% of its Notice of Inventions, an abbreviated version of the invention disclosure, approved by October 2014. App. 30-31. Further, despite Trzaska‘s complaint about the patentability of certain applications, Trzaska acknowledged that in 2014, L‘Oréal began “an internal initiative to improve the quality of patent applications being filed by L‘Oréal.” App. 33. Highlights of this 2014 initiative included “requiring inventors to provide examples evidencing that the proposed inventions performed as represented....” App. 33. This initiative supplemented the already robust “vetting” process that was in place to ensure that “the subject matter of the invention is novel and unobvious” and to assist the reviewing patent attorney in making a “good faith determination whether the subject matter in an invention disclosure is potentially patentable.” App. 32-33.
II.
My colleagues in the majority maintain that the District Court misapplied the
A.
To state a prima facie case under CEPA, a plaintiff must establish that:
(1) he or she reasonably believed that his or her employer‘s conduct was violating either a law, rule, or regulation promulgated pursuant to law, or a clear mandate of public policy; (2) he or she performed a ‘whistle-blowing’ activity described in
Dzwonar v. McDevitt, 177 N.J. 451, 828 A.2d 893, 900 (2003).
Trzaska‘s amended complaint fails to satisfy the first element of the CEPA prima facie case. This is because he has failed to meet the requirement that “a plaintiff must set forth facts that would support an objectively reasonable belief that a violation has occurred.” Id. at 901.
The New Jersey Supreme Court, in evaluating the reasonableness of a plaintiff‘s beliefs regarding an employer‘s conduct, has cautioned that CEPA “is not intended to spawn litigation concerning the most trivial or benign employee complaints.” Estate of Roach v. TRW, Inc., 164 N.J. 598, 754 A.2d 544, 552 (2000). CEPA thus does not protect “chronic complainers or those who simply disagree with their employer‘s lawful actions.” Blackburn v. United Parcel Serv., Inc., 179 F.3d 81, 93 n.4 (3d Cir. 1999); see also Young v. Schering Corp., 275 N.J. Super. 221, 645 A.2d 1238, 1246 (N.J. Super. Ct. App. Div. 1994) (noting that CEPA “was not intended to provide a remedy for wrongful discharge for employees who simply disagree with an employer‘s decision, where that decision is entirely lawful“), aff‘d, 141 N.J. 16, 660 A.2d 1153 (1995). Nor does it “shelter every alarmist who disrupts his employer‘s operations by constantly declaring that illegal activity is afoot—or ... is about to be afoot.” Blackburn, 179 F.3d at 93 n.4. New Jersey courts have therefore held that a plaintiff who “simply disagrees with the manner in which the [employer] is operating” may not proceed on a CEPA claim. Hitesman v. Bridgeway, Inc., 218 N.J. 8, 93 A.3d 306, 320 (2014) (quoting Klein v. Univ. of Med. & Dentistry of N.J., 377 N.J. Super. 28, 42, 871 A.2d 681, 689 (N.J. Super. Ct. App. Div. 2005)).
To determine whether an employee‘s belief should “be considered ‘reasonable,‘” our esteemed colleague, Judge Barry, then sitting as a District Judge, correctly observed “that belief must be such that ‘a reasonable lay person would conclude that illegal activity was going on’ or, at the very least, is imminent.” Blackburn v. United Parcel Serv., Inc., 3 F. Supp. 2d 504, 515 (D.N.J. 1998) (quoting Young, 645 A.2d at 1238), aff‘d, 179 F.3d 81 (3d Cir. 1999). Accordingly, subject to the exception discussed infra, a cause of action under CEPA is stated only when illegal activity is occurring or imminent.
With these essential principles in mind, I turn to the factual makeup of this case. Even taking the factual allegations in the light most favorable to him, Trzaska did not allege an objectively reasonable belief of past or imminent wrongdoing. Trzaska averred no facts suggesting that L‘Oréal requested or demanded that he relinquish his professional obligations in evaluating or submitting patent applications. See Oral Arg. Tr. at 5 (Trzaska‘s counsel conceding that L‘Oréal did not tell Trzaska to file “frivolous or unwarranted patent claims“); see generally Johnson v. N.J. Higher Educ. Student Assistance Auth., No. A-3102-13T1, 2015 WL 6739525, at *6 (N.J. Super. Ct. App. Div. Nov. 5, 2015) (concluding the plaintiff‘s assertions were “patently insufficient” to support a CEPA claim when the plaintiff failed to allege that her employer “told her to fabricate facts, falsify documents, or falsely implicate others“). Nor did Trzaska allege that he informed his employer before September 2014 that he was displeased with the quality of invention disclosures or concerned about the quota policy. In this regard, the only specific notice that Trzaska alleges that he gave to his employer is that he advised the company “that neither he nor the patent attorneys who reported to him were willing to file patent applications that the attorneys believed were not patentable....” App. 34. Yet, the amended complaint failed to identify even a single defective patent application that was submitted at any point during Trzaska‘s ten years of employment at L‘Oréal—a period that entirely coincided with the existence of the global quota policy. See Oral Arg. Tr. at 5 (Trzaska‘s counsel responding in the negative to the question were any “frivolous or unwarranted patent claims ... filed by Mr. Trzaska and/or his office?“). Such conclusory allegations fail to support the requirement that illegal activity was afoot or imminent. See Blackburn, 3 F. Supp. 2d at 515.
Trzaska‘s allegations in the amended complaint actually refute rather than support his claims of wrongdoing. For instance, the amended complaint detailed at length the elaborate procedures used to “vet[ ]” an invention disclosure as well as the “internal initiative” L‘Oréal adopted to improve overall quality in patent applications. App. 32-33. These detailed factual allegations undercut any suggestion that management encouraged the submission of frivolous patent applications. Any claim of wrongdoing on L‘Oréal‘s part is further undermined by the fact that, at the time of his termination, Trzaska‘s team had nearly completed its annual quota requirement and seemingly had ample time to submit the remaining invention disclosures.
These facts, taken together, suggest that Trzaska at most alleged a policy disagreement with L‘Oréal over the efficacy of the quota system. Such “routine dispute[s] in the workplace,” however, are insufficient to state a viable CEPA claim. See Hitesman, 93 A.3d at 319; see also Klein, 871 A.2d at 690 (rejecting a CEPA claim when the plaintiff‘s concerns were essentially
Trzaska‘s arguments to the contrary are unavailing. Trzaska argues, for instance, that he pled a viable claim because he alleged that he “and his patent attorney colleagues were informed that if the 2014 target of ... filed patent applications was not met, there would be consequences which would negatively impact their careers and continued employment.” App. 32. Trzaska has not plausibly suggested, however, that the quota itself was improper or unlawful. See Young, 645 A.2d at 1246 (affirming the dismissal of a CEPA claim where the challenged conduct “was not unlawful or wrongful in any way“).2 Moreover, this bare, unspecific factual allegation should not be credited. There is no indication in the amended complaint, for instance, of who “informed” Trzaska or his co-workers of these consequences. See Iqbal, 556 U.S. at 678 (“[A] complaint [does not] suffice if it tenders ‘naked assertion[s]’ devoid of ‘further factual enhancement.‘” (quoting Twombly, 550 U.S. at 557)); Evancho v. Fisher, 423 F.3d 347, 354 (3d Cir. 2005) (“Without addressing any of these facets of her transfer in her amended complaint [such as when the decision to transfer was made, the steps taken to effect the transfer, who prepared the transfer forms, and who signed the forms], Evancho‘s allegation that Attorney General Fisher himself and/or his ‘underlings’ carried out the transfer is simply a ‘bald assertion,’ which a court is not required to credit in deciding a motion to dismiss.“). What is evident from an email attachment to the amended complaint is that Trzaska and his colleagues were encouraged by management to fulfill their job responsibilities to meet the existing quota. See Hartig Drug Co. Inc. v. Senju Pharm. Co., 836 F.3d 261, 268 (3d Cir. 2016) (observing that a court considering a
Trzaska also relies on the fact that one his co-employees opted to retire instead of complying with company policy. Trzaska Br. 41. That another employee disapproved of L‘Oréal‘s business practice, however, does not automatically render Trzaska‘s beliefs objectively reasonable. See Blackburn, 179 F.3d at 93 n.4 (noting that reasonableness is measured according to the standard of a “reasonable lay person” (quoting Young, 645 A.2d at 1244)). Trzaska finally maintains that his belief of wrongdoing was reasonable because L‘Oréal‘s own scientists admitted their inventions were not patentable. Trzaska Br. 41. This assertion, however, is merely a bald allegation unsupported by well-pleaded facts. Trzaska neither identified the inventors who expressed such reservations nor singled out any allegedly questionable inventions. The District Court did not err in ruling that such conclusory allegations do not state a plausible claim.
B.
I would also affirm on the independent basis that Trzaska did not meet the heightened standard—requiring an actual viola-
Trzaska, as an attorney, must satisfy this more rigorous standard. Because he did not allege that L‘Oréal‘s conduct “actually violate[d]” an RPC, however, he has not met the heightened standard articulated in Tartaglia, 961 A.2d at 1185. Accordingly, he has failed to allege a plausible entitlement to relief under CEPA. I would also affirm on this independent basis.
III.
In sum, I do not believe that the District Court erred in concluding that Trzaska did not plead a viable CEPA claim because he failed to establish that L‘Oréal had or would imminently violate a law, rule, regulation, or a clear mandate of public policy. I would also hold that Trzaska failed to satisfy the heightened standard applying to him as an attorney. Accordingly, I would affirm the District Court‘s dismissal of his CEPA claim for failure to state a claim. I respectfully dissent.
Notes
A practitioner shall not bring or defend a proceeding, or assert or controvert an issue therein, unless there is a basis in law and fact for doing so that is not frivolous, which includes a good-faith argument for an extension, modification or reversal of existing law[;]
and
A practitioner shall not knowingly ... [m]ake a false statement of fact or law to a tribunal or fail to correct a false statement of material fact or law previously made to the tribunal by the practitioner....
On this point, the dissent believes that we should hold Trzaska to a higher standard because he is an attorney. Dissent at 167-68. It cites to Tartaglia v. UBS PaineWebber Inc., 197 N.J. 81, 961 A.2d 1167 (2008), for this assertion. Tartaglia dealt with a claim brought under Pierce v. Ortho Pharmaceutical Corporation, 84 N.J. 58, 417 A.2d 505 (1980), which created the common-law antecedent to CEPA. In Tartaglia, the plaintiff sought relief from wrongful termination following whistleblowing of her employer‘s own ethical violations. The New Jersey Supreme Court determined that the plaintiff, an attorney who internally complained about her employer‘s RPC violation, was held to a “higher standard” of demonstrating an actual RPC violation occurred (as opposed to a reasonable belief that one occurred) because, as an attorney, she was more knowledgeable about the RPCs and under them was obligated to report another‘s violation. Tartaglia, 961 A.2d at 1184-85. That case does not apply to what is before us: it dealt with an attorney-employer‘s own RPC violations (ours does not); a Pierce whistle-blowing claim regarding that violation (ours does not); and a claim that has a statutory corollary in
